How nanoparticles interact with cancer cells

Cancer Treatment and Research

Volumn 166, Issue , 2015, Pages 227-244

  Syed, Abdullah ^a   Chan, Warren C W ^a  

^a UNIVERSITY OF TORONTO   (Canada)

Author keywords

Cancer targeting; Nano biointeractions; Nanomedicine; Nanoparticle cell interaction

Indexed keywords

CAVEOLIN 1; CLATHRIN; GOLD NANOPARTICLE; NANOPARTICLE; OPSONIN; TRANSCRIPTION FACTOR AP 2; NANOCONJUGATE;

ADSORPTION; ARTICLE; BINDING AFFINITY; CANCER CELL; CELL INTERACTION; ENDOCYTOSIS; ENDOSOME; EXOCYTOSIS; INTRACELLULAR SIGNALING; MOLECULAR INTERACTION; NONHUMAN; PARTICLE SIZE; PHAGOCYTE; PHAGOCYTOSIS; PREVALENCE; PRIORITY JOURNAL; PROTEIN ASSEMBLY; PROTEIN BINDING; PROTEIN INTERACTION; REPRODUCIBILITY; ANIMAL; CHEMISTRY; HUMAN; NANOMEDICINE; NEOPLASMS; PHYSIOLOGY; PROCEDURES;

ANIMALS; ENDOCYTOSIS; HUMANS; NANOCONJUGATES; NANOMEDICINE; NEOPLASMS;

EID: 84928553421     PISSN: 09273042     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-3-319-16555-4_10     Document Type: Article

References (69)

1. Park K (2013) Facing the truth about nanotechnology in drug delivery. ACS Nano 7(9):7442-7447
2. Jain RK, Stylianopoulos T (2010) Delivering nanomedicine to solid tumors. Nat Rev Clin Oncol 7(11):653-664
3. Hobbs SK et al (1998) Regulation of transport pathways in tumor vessels: role of tumor type and microenvironment. Proc Natl Acad Sci USA 95(8):4607-4612
4. Stylianopoulos T, Jain RK (2013) Combining two strategies to improve perfusion and drug delivery in solid tumors. Proc Natl Acad Sci USA 110(46):18632-18637
5. Chauhan VP, Jain RK (2013) Strategies for advancing cancer nanomedicine. Nat Mater 12(11):958-962
6. Jain RK (2013) Normalizing tumor microenvironment to treat cancer: bench to bedside to biomarkers. J Clin Oncol 31(17):2205-2218
7. Choi HS et al (2007) Renal clearance of quantum dots. Nat Biotechnol 25(10):1165-1170
8. Champion JA, Mitragotri S (2006) Role of target geometry in phagocytosis. Proc Natl Acad Sci USA 103(13):4930-4934
9. Iversen TG, Frerker N, Sandvig K (2012) Uptake of ricinB-quantum dot nanoparticles by a macropinocytosis-like mechanism. J Nanobiotechnol 10:33
10. Rejman J et al (2004) Size-dependent internalization of particles via the pathways of clathrinand caveolae-mediated endocytosis. Biochem J 377(Pt 1):159-169
11. Gabrielson NP, Pack DW (2009) Efficient polyethylenimine-mediated gene delivery proceeds via a caveolar pathway in HeLa cells. J Control Release 136(1):54-61
12. Doherty GJ, McMahon HT (2009) Mechanisms of endocytosis. Annu Rev Biochem 78:857-902
13. Gao H et al (2013) Ligand modified nanoparticles increases cell uptake, alters endocytosis and elevates glioma distribution and internalization. Sci Rep 3:2534
14. Henne WM et al (2010) FCHo proteins are nucleators of clathrin-mediated endocytosis. Science 328(5983):1281-1284
15. Honing S et al (2005) Phosphatidylinositol-(4,5)-bisphosphate regulates sorting signal recognition by the clathrin-associated adaptor complex AP2. Mol Cell 18(5):519-531
16. Tsuji T, Yoshitomi H, Usukura J (2013) Endocytic mechanism of transferrin-conjugated nanoparticles and the effects of their size and ligand number on the efficiency of drug delivery. Microscopy (Oxford) 62(3):341-352
17. Ehrlich M et al (2004) Endocytosis by random initiation and stabilization of clathrin-coated pits. Cell 118(5):591-605
18. Cheng Y et al (2007) Cryo-electron tomography of clathrin-coated vesicles: structural implications for coat assembly. J Mol Biol 365(3):892-899
19. Veiga E, Cossart P (2005) Listeria hijacks the clathrin-dependent endocytic machinery to invade mammalian cells. Nat Cell Biol 7(9):894-900
20. Georgieva JV et al (2011) Surface characteristics of nanoparticles determine their intracellular fate in and processing by human blood-brain barrier endothelial cells in vitro. Mol Ther 19 (2):318-325
21. Sandvig K et al (2008) Clathrin-independent endocytosis: from nonexisting to an extreme degree of complexity. Histochem Cell Biol 129(3):267-276
22. Choi CH et al (2013) Mechanism for the endocytosis of spherical nucleic acid nanoparticle conjugates. Proc Natl Acad Sci USA 110(19):7625-7630
23. Nevins AK, Thurmond DC (2006) Caveolin-1 functions as a novel Cdc42 guanine nucleotide dissociation inhibitor in pancreatic beta-cells. J Biol Chem 281(28):18961-18972
24. Bae YM et al (2012) Endocytosis, intracellular transport, and exocytosis of lanthanide-doped upconverting nanoparticles in single living cells. Biomaterials 33(35):9080-9086
25. Iversen TG, Skotland T, Sandvig K (2011) Endocytosis and intracellular transport of nanoparticles: Present knowledge and need for future studies. Nano Today 6(2):176-185
26. Grimmer S, van Deurs B, Sandvig K (2002) Membrane ruffling and macropinocytosis in A431 cells require cholesterol. J Cell Sci 115(Pt 14):2953-2962
27. Herd H et al (2013) Nanoparticle geometry and surface orientation influence mode of cellular uptake. ACS Nano 7(3):1961-1973
28. Owens DE 3rd, Peppas NA (2006) Opsonization, biodistribution, and pharmacokinetics of polymeric nanoparticles. Int J Pharm 307(1):93-102
29. Rodriguez PL et al (2013) Minimal "Self" peptides that inhibit phagocytic clearance and enhance delivery of nanoparticles. Science 339(6122):971-975
30. Tenzer S et al (2013) Rapid formation of plasma protein corona critically affects nanoparticle pathophysiology. Nat Nanotechnol 8(10):772-781
31. Tenzer S et al (2011) Nanoparticle size is a critical physicochemical determinant of the human blood plasma corona: a comprehensive quantitative proteomic analysis. ACS Nano 5(9):7155-7167
32. Walkey CD et al (2014) Protein corona fingerprinting predicts the cellular interaction of gold and silver nanoparticles. ACS Nano 8(3):2439-2455
33. Lesniak A et al (2012) Effects of the presence or absence of a protein corona on silica nanoparticle uptake and impact on cells. ACS Nano 6(7):5845-5857
34. Ge C et al (2011) Binding of blood proteins to carbon nanotubes reduces cytotoxicity. Proc Natl Acad Sci USA 108(41):16968-16973
35. Sahoo B et al (2007) Spontaneous formation of a protein corona prevents the loss of quantum dot fluorescence in physiological buffers. Chem Phys Lett 445(4-6):217-220
36. Albanese A et al (2014) Secreted biomolecules alter the biological identity and cellular interactions of nanoparticles. ACS Nano 8(6):5515-5526
37. Oh N, Park JH (2014) Surface chemistry of gold nanoparticles mediates their exocytosis in macrophages. ACS Nano 8(6):6232-6241
38. Salvati A et al (2013) Transferrin-functionalized nanoparticles lose their targeting capabilities when a biomolecule corona adsorbs on the surface. Nat Nanotechnol 8:137-143
39. Walkey CD, Chan WC (2012) Understanding and controlling the interaction of nanomaterials with proteins in a physiological environment. Chem Soc Rev 41(7):2780-2799
40. Chinen AB, Guan CM, Mirkin CA (2014) Spherical nucleic acid nanoparticle conjugates enhance g-quadruplex formation and increase serum protein interactions. Angew Chem Int Ed 54(2):527-531
41. Kamaly N et al (2012) Targeted polymeric therapeutic nanoparticles: design, development and clinical translation. Chem Soc Rev 41(7):2971-3010
42. García KP et al (2014) Zwitterionic coatings: zwitterionic-coated "stealth" nanoparticles for biomedical applications: recent advances in countering biomolecular corona formation and uptake by the mononuclear phagocyte system (small 13/2014). Small 10(13):2505
43. Walkey CD et al (2012) Nanoparticle size and surface chemistry determine serum protein adsorption and macrophage uptake. J Am Chem Soc 134(4):2139-2147
44. Zhang Y, Kohler N, Zhang M (2002) Surface modification of superparamagnetic magnetite nanoparticles and their intracellular uptake. Biomaterials 23(7):1553-1561
45. Gref R et al (2000) 'Stealth' corona-core nanoparticles surface modified by polyethylene glycol (PEG): influences of the corona (PEG chain length and surface density) and of the core composition on phagocytic uptake and plasma protein adsorption. Colloids Surf B 18(3-4): 301-313
46. Dai Q, Walkey C, Chan WC (2014) Polyethylene glycol backfilling mitigates the negative impact of the protein corona on nanoparticle cell targeting. Angew Chem Int Ed Engl 53 (20):5093-5096
47. Prapainop K, Witter DP, Wentworth P Jr (2012) A chemical approach for cell-specific targeting of nanomaterials: small-molecule-initiated misfolding of nanoparticle corona proteins. J Am Chem Soc 134(9):4100-4103
48. Kah JC et al (2012) Exploiting the protein corona around gold nanorods for loading and triggered release. ACS Nano 6(8):6730-6740
49. Monopoli MP et al (2012) Biomolecular coronas provide the biological identity of nanosized materials. Nat Nanotechnol 7(12):779-786
50. Gratton SE et al (2008) Microfabricated particles for engineered drug therapies: elucidation into the mechanisms of cellular internalization of PRINT particles. Pharm Res 25 (12):2845-2852
51. Chithrani BD, Ghazani AA, Chan WC (2006) Determining the size and shape dependence of gold nanoparticle uptake into mammalian cells. Nano Lett 6(4):662-668
52. Lu F et al (2009) Size effect on cell uptake in well-suspended, uniform mesoporous silica nanoparticles. Small 5(12):1408-1413
53. Varela JA et al (2012) Quantifying size-dependent interactions between fluorescently labeled polystyrene nanoparticles and mammalian cells. J Nanobiotechnol 10:39
54. Cho EC, Zhang Q, Xia Y (2011) The effect of sedimentation and diffusion on cellular uptake of gold nanoparticles. Nat Nanotechnol 6(6):385-391
55. Agarwal R et al (2013) Mammalian cells preferentially internalize hydrogel nanodiscs over nanorods and use shape-specific uptake mechanisms. Proc Natl Acad Sci USA 110 (43):17247-17252
56. Wiley DT et al (2013) Transcytosis and brain uptake of transferrin-containing nanoparticles by tuning avidity to transferrin receptor. Proc Natl Acad Sci USA 110(21):8662-8667
57. Gao H, Shi W, Freund LB (2005) Mechanics of receptor-mediated endocytosis. Proc Natl Acad Sci USA 102(27):9469-9474
58. Henne WM et al (2007) Structure and analysis of FCHo2 F-BAR domain: a dimerizing and membrane recruitment module that effects membrane curvature. Structure 15(7):839-852
59. Harari D, Yarden Y (2000) Molecular mechanisms underlying ErbB2/HER2 action in breast cancer. Oncogene 19(53):6102-6114
60. Jiang W et al (2008) Nanoparticle-mediated cellular response is size-dependent. Nat Nanotechnol 3(3):145-150
61. Salvati A et al (2013) Transferrin-functionalized nanoparticles lose their targeting capabilities when a biomolecule corona adsorbs on the surface. Nat Nanotechnol 8(2):137-143
62. Plank C et al (1994) The influence of endosome-disruptive peptides on gene transfer using synthetic virus-like gene transfer systems. J Biol Chem 269(17):12918-12924
63. Cho YW, Kim JD, Park K (2003) Polycation gene delivery systems: escape from endosomes to cytosol. J Pharm Pharmacol 55(6):721-734
64. Hatakeyama H et al (2009) A pH-sensitive fusogenic peptide facilitates endosomal escape and greatly enhances the gene silencing of siRNA-containing nanoparticles in vitro and in vivo. J Controlled Release 139(2):127-132
65. Yanes RE et al (2013) Involvement of lysosomal exocytosis in the excretion of mesoporous silica nanoparticles and enhancement of the drug delivery effect by exocytosis inhibition. Small 9(5):697-704
66. Chithrani BD, Chan WC (2007) Elucidating the mechanism of cellular uptake and removal of protein-coated gold nanoparticles of different sizes and shapes. Nano Lett 7(6):542-550
67. Kim CS et al (2014) The role of surface functionality in nanoparticle exocytosis. Adv Healthc Mater 3:5-7
68. Chou LY, Ming K, Chan WC (2011) Strategies for the intracellular delivery of nanoparticles. Chem Soc Rev 40(1):233-245
69. Ashley CE et al (2011) The targeted delivery of multicomponent cargos to cancer cells by nanoporous particle-supported lipid bilayers. Nat Mater 10(5):389-397